AI-generated summary
This randomized, placebo-controlled trial in women with facial photodamage compared methyl aminolevulinate plus red light with placebo plus red light using skin biopsies and blinded histological scoring. The authors report that dermal thickness increased after MAL plus red light and that collagen, elastic tissue and perifollicular fibrosis appeared improved, but most between-treatment differences were not statistically significant.
- Participants
- 38
- Who or what was studied
- Women with facial photodamage; 65 screened, skin samples from 38 analysed
- Limits stated in the abstract
- The authors state that the non-significant differences may reflect the low power of the study or a scoring method that failed to detect histopathological differences.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Collagen, Photodynamic therapy, Placebo-controlled, Red light therapy, Inflammation, GRADE, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.